Clinical Trials

25 enrolled 12 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body

NCT06900686 2025-03-28

Clinical Application of PD-1 Inhibitor in Colorectal Cancer for Improving Survival

Completed

458 enrolled

Phase 3 Not yet recruiting

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms, Rectal Neoplasms

NCT06647563 2024-10-18

Neoadjuvant Toripalimab + Chemotherapy ± Cetuximab in Locally Advanced Head and Neck Squamous Cell Carcinoma (Neo-ICT)

355 enrolled

Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck

NCT02834052 2024-06-07

Pembrolizumab + Poly-ICLC in MRP Colon Cancer

Phase 1/2 Completed

42 enrolled 13 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Colonic Neoplasms

NCT02735239 2024-03-22

Study of Anti-PD-L1 in Combination With Chemo(Radio)Therapy for Oesophageal Cancer

Phase 1/2 Completed

73 enrolled 18 charts

Adenocarcinoma Of Esophagus, Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT05626569 2024-01-03

Anti-PD-1 Immunotherapy Combined With SBRT for Patients With Oligometastatic ESCC

40 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04271384 2023-12-26

Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer

25 enrolled

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT05235737 2023-08-31

PIRG

Phase 4 Recruiting

36 enrolled

CNS

Parkinson Disease 4, Autosomal Dominant Lewy Body, Glioblastoma

NCT05941338 2023-07-12

HNC-SYSU-001

Phase 2 Recruiting

100 enrolled

Head & Neck

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT05386056 2022-11-28

Pembrolizumab and Photodynamic Therapy in Previously Treated Metastatic Esophageal Squamous Cell Carcinoma

54 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

NCT05519202 2022-08-29

Exploratory Clinical Study of Penpulimab Combined With SOX in the Perioperative Treatment of Gastric Cancer

47 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT02968940 2022-06-29

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

6 enrolled 10 charts

CNS

Parkinson Disease 4, Autosomal Dominant Lewy Body, Glioblastoma, Glioma

NCT04812002 2022-06-03

Study of PD-1 Antibody and Bevacizumab in the Treatment of High-risk GTN After Combined Chemotherapy

Phase 2 Recruiting

20 enrolled

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Gestational Trophoblastic Disease

NCT05392686 2022-05-26

PD1 and PARP for Maintenance Therapy in NSLLC

52 enrolled

Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT02549209 2022-03-02

Pembro/Carbo/Taxol in Endometrial Cancer

46 enrolled 13 charts

Gynecologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Endometrial Neoplasms

NCT02983006 2021-10-18

Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma

Phase 1 Completed

12 enrolled

Dermatologic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT04886193 2021-05-13

FLOT Combined With PD-1 in the First-line Treatment of Patients With Advanced Gastric Cancer and Peritoneal Metastasis

Phase NA Unknown

20 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT04589494 2021-01-14

Effect of Tramadol Versus Morphine on PD1 and PD1-ligand in Patients With Chronic Cancer Pain

Phase 2/3 Unknown

15 enrolled

Parkinson Disease 4, Autosomal Dominant Lewy Body, Chronic Pain

NCT04530227 2020-11-13

Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC